Large-scale protein and gene profiling have massively expanded the landscape of cancer-associated proteins and gene mutations, but it has been difficult to discern whether they play an active role in the disease or are innocent bystanders.
Cardiology’s Bid to Defect From ABIM Plows Ahead
ATLANTA — Cardiology’s bid to escape what many see as burdensome requirements for board certification maintenance under the American Board of Internal Medicine (ABIM) is
April 8, 2024